CLL11: Salvage Therapy with Obinutuzumab and Chlorambucil (Clb) After Failure of Clb Alone for Patients with CLL and Comorbidities


CLL11: Salvage Therapy with Obinutuzumab and Chlorambucil (Clb) After Failure of Clb Alone for Patients with CLL and Comorbidities
Slides from a presentation at ASH 2014 and transcribed comments from a recent interview with Jonathan W Friedberg, MD, MMSc (1/8/15)
Goede V et al. Salvage therapy with obinutuzumab (GA101) plus chlorambucil (Clb) after treatment failure of Clb alone in patients with chronic lymphocytic leukemia (CLL) and comorbidities: Results of the CLL11 study. Proc ASH 2014;Abstract 3327.

Dr Friedberg is Samuel Durand Professor of Medicine and Director of the Wilmot Cancer Center at the University of Rochester in Rochester, New York.